Establishment of HIV-1 model cell line GHOST(3) with stable DRiP78 and NHERF1 knockdown

Lin Zhang1, Xu-He Huang2, Ping-Ping Zhou2

  • 1Center for Translational Medicine, Huaihe Clinical Institute, Henan University, Kaifeng 475000, China.

Insights

Researchers created a new cell line to study HIV-1 entry. This cell line, GHOST(3) with dopamine receptor-interacting protein 78 (DRiP78) and Na(+)-H(+) exchanger regulatory factor 1 (NHERF1) knockdown, is the first with defects in HIV-1 co-receptor interactions.

Area of Science:

  • Virology
  • Cell Biology
  • Molecular Medicine

Background:

  • Chemokine receptors CXCR4 and CCR5 are crucial for HIV-1 entry.
  • Dopamine receptor-interacting protein 78 (DRiP78) and Na(+)-H(+) exchanger regulatory factor 1 (NHERF1) interact with these co-receptors.
  • DRiP78 and NHERF1 influence co-receptor trafficking and HIV-1 production.

Purpose of the Study:

  • To investigate the role of DRiP78 and NHERF1 in HIV-1 replication.
  • To establish a stable cell line for studying HIV-1 co-receptor interactions.
  • To create a model for analyzing molecular defects in HIV-1 co-receptor pathways.

Main Methods:

  • Designed short hairpin RNAs (shRNAs) targeting DRiP78 and NHERF1.
  • Constructed lentiviral plasmids for shRNA expression.
  • Transduced GHOST(3) cells and selected for stable knockdown using Blasticidin.

Main Results:

  • Successfully established GHOST(3) cells with stable knockdown of DRiP78 and NHERF1.
  • Created the first stable cell line with defects in HIV-1 co-receptor-interacting molecules.
  • This cell line serves as a novel model for HIV-1 research.

Conclusions:

  • The developed GHOST(3) cell line with DRiP78 and NHERF1 knockdown provides a unique tool for studying HIV-1 entry mechanisms.
  • This model allows for the investigation of how co-receptor-interacting proteins affect viral replication.
  • Further research can utilize this cell line to explore potential therapeutic targets for HIV-1.

Related Concept Videos